Achmea Investment Management B.V. Neurocrine Biosciences Inc Transaction History
Achmea Investment Management B.V.
- $6.06 Billion
- Q3 2024
A detailed history of Achmea Investment Management B.V. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Achmea Investment Management B.V. holds 8,362 shares of NBIX stock, worth $1.03 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,362
Previous 3,143
166.05%
Holding current value
$1.03 Million
Previous $433,000
122.4%
% of portfolio
0.02%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding NBIX
# of Institutions
642Shares Held
94.3MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.74 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.23 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$631 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$316 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$229 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...